Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Critical Outcome Technologies begins development of oral COTI-2 formulation

May 20, 2011

New RAC-alpha serine/threonine-protein kinase inhibitors claimed

May 20, 2011

Abiraterone acetate plus prednisone provides clinical benefit in metastatic CRPC

May 20, 2011

Biothera initiates dosing in phase III trial of Imprime PGG with Erbitux

May 19, 2011

University of Michigan presents new Smac mimetics with IAP-inhibiting activity

May 19, 2011

Novel protein kinase inhibitors disclosed

May 19, 2011

ERYtech and Teva sign long-term agreement on Graspa

May 18, 2011

Phase II study begins for BKM-120 in recurrent glioblastoma

May 18, 2011

New anticancer antofine and cryptopleurine derivatives disclosed

May 18, 2011

AlloStem Therapeutics designs novel MEK inhibitors

May 18, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...